Biosimilar medicines and patient registries – expectations, limitations, and opportunities

Biology therapies in a various medical specializations and for a broad spectrum of indications were launched during last two decades. As a new in class the therapies were obliged to provide additional data re gar ding efficacy and safety after their real medical practice integration. Patient registr...

Full description

Bibliographic Details

Published in:	Acta medica martiniana Vol. 17; no. 3; pp. 39 - 51
Main Authors:	Sutka, R, Pec, J, Pecova, T
Format:	Journal Article
Language:	English
Published:	Martin De Gruyter Open 01-12-2017 De Gruyter Poland Sciendo
Subjects:	Biological products biologically similar drugs biology therapy registries biosimilars Clinical outcomes Drug therapy Health informatics Health technology assessment HTA (health technology assessment) Patients
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!